US Patent Issued to FIMECS on Oct. 27 for "Heterocyclic compound" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,287, issued on Oct. 27, was assigned to FIMECS Inc. (Fujisawa, Japan).

"Heterocyclic compound" was invented by Yusuke Tominari (Sagamihara, Japan), Yoshihide Tomata (Tsukuba, Japan), Kanae Gamo (Yokohama, Japan) and Naomi Kitamoto (Amagasaki, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "It is to provide a novel heterocyclic compound which has the effect of inducing degradation of interleukin-1 receptor-associated kinase-M (IRAK-M) protein and is expected to be useful for the prevention/treatment of cancer, fibrosis, infectious diseases, etc. The present invention provides a compound represented by the following formula (I) or a pharmaceutica...